- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/12 - Antidiarrhoeals
Patent holdings for IPC class A61P 1/12
Total number of patents in this class: 994
10-year publication summary
|
29
|
44
|
48
|
66
|
76
|
75
|
84
|
83
|
74
|
21
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2961 |
23 |
| Finch Therapeutics Holdings, LLC | 71 |
22 |
| Société des Produits Nestlé S.A. | 9672 |
21 |
| N.V. Nutricia | 1022 |
18 |
| Napo Pharmaceuticals, Inc. | 40 |
13 |
| University of Florida Research Foundation, Inc. | 3883 |
12 |
| Albireo AB | 157 |
12 |
| Nestec S.A. | 2777 |
11 |
| Array BioPharma Inc. | 551 |
9 |
| DSM IP Assets B.V. | 5856 |
8 |
| Ajinomoto Co., Inc. | 2337 |
8 |
| The Regents of the University of California | 18943 |
7 |
| Abbott Laboratories | 2542 |
7 |
| Astellas Pharma Inc. | 1145 |
7 |
| Novartis AG | 11238 |
6 |
| Janssen Pharmaceutica N.V. | 3839 |
6 |
| Novozymes A/S | 3314 |
6 |
| Compagnie Gervais Danone | 894 |
6 |
| Meiji Co., Ltd. | 668 |
6 |
| Thetis Pharmaceuticals LLC | 20 |
6 |
| Other owners | 780 |